Anthony P. Waclawski

EVP and Global Head of Regulatory Affairs

Anthony Waclawski, Ph.D. joined Brainstorm in September 2020 and serves as Executive Vice President and Global Head of Regulatory Affairs.

Dr. Waclawski is an experienced healthcare professional and a globally recognized regulatory leader with over 35 years of multinational experience in FDA regulatory approvals, biologics license applications (BLAs), New Drug Applications (NDAs), and FDA Advisory Committees. Prior to his appointment at BrainStorm, Dr. Waclawski spent 35 years of increasing responsibility at Bristol-Myers Squibb, most recently as Vice President and Head, Regulatory and Pharmaceutical Sciences, Cardiovascular, Immunosciences, Fibrosis, and Genetically-defined diseases. In this role, he was responsible for the strategic and operational deliverables of regulatory, biostatistics, clinical pharmacology, and pharmacometrics for the development assets in these areas. Dr. Waclawski’s experience spans a broad range of regulatory capabilities across multiple therapeutic areas and geographies, guiding successful FDA interactions and establishing and executing successful global regulatory strategies.

Scroll to Top